Stella Pharma Corporation (TSE: 4888)
Health Care · Pharmaceuticals · JP
¥394.00
-7.51% today · +10.1% 1Y
Stella Pharma Corporation (TSE: 4888) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $92.15M and employs 47 people.
Over the last twelve months the share price has gained 10.1%, trading between 200.00 and 995.00.
Tweenvest scores Stella Pharma Corporation across four factors: quality 41/100, value 67/100, growth 62/100. Its strongest factor is value.
4888 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $92.15M
- Revenue (TTM)
- $1.99M
- P/E
- —
- EPS
- -24.87
- Dividend yield
- —
- Beta (5Y)
- 0.33
- 52-week high
- ¥995.00
- 52-week low
- ¥200.00
- Avg volume (3M)
- —
- Shares outstanding
- 37.03M
- Employees
- 47
- Next earnings
- —
About Stella Pharma Corporation
Stella Pharma Corporation is a pharmaceutical company that handles the complete process of drug development, from research and manufacturing to distribution. A core area of its specialization is in therapeutic agents for boron neutron capture therapy (BNCT). Their product lineup includes SPM-011, a boron-containing drug designed for BNCT, which is utilized in the treatment of head and neck cancer, recurrent malignant glioma, meningioma, malignant melanoma, and angiosarcoma. Founded in 2007, Stella Pharma Corporation maintains its headquarters in Osaka, Japan.
- ISIN
- JP3399680002
- Founded
- 2007
- Listed since
- Apr 22, 2021
- Exchange
- The Tokyo Stock Exchange
- Currency
- JPY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Unité de Fabrication des Médicaments S.ABVMT: UMED | $93.89M | DT8.77 | -0.34% |
| PT Merck TbkIDX: MERK | $93.89M | Rp3,750.00 | -1.06% |
| AlzeCure Pharma AB (publ)OM: ALZCUR | $93.23M | Skr7.10 | +5.03% |
| Rani Therapeutics Holdings, Inc.NasdaqGM: RANI | $92.22M | $0.76 | -5.26% |
| Shree Ganesh Remedies LimitedBSE: 540737 | $90.37M | Rs681.25 | -1.72% |
| Renascience Inc.TSE: 4889 | $89.79M | ¥1,032.00 | -6.44% |
| Dong Sung Bio Pharm.Co.,Ltd.KOSE: A002210 | $89.60M | ₩1,283.00 | +0.39% |
| Neumora Therapeutics, Inc.NasdaqGS: NMRA | $89.38M | $0.44 | -8.05% |
Figures last refreshed Oct 11, 2026.